These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33181704)

  • 1. Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus.
    Li L; Guan Z; Li R; Zhao W; Hao G; Yan Y; Xu Y; Liao L; Wang H; Gao L; Wu K; Gao Y; Li Y
    Medicine (Baltimore); 2020 Nov; 99(46):e23212. PubMed ID: 33181704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
    Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO
    Clin Pharmacokinet; 2013 May; 52(5):373-84. PubMed ID: 23475568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pregnancy on the Pharmacokinetics of Metformin.
    Liao MZ; Flood Nichols SK; Ahmed M; Clark S; Hankins GD; Caritis S; Venkataramanan R; Haas D; Quinney SK; Haneline LS; Tita AT; Manuck T; Wang J; Thummel KE; Brown LM; Ren Z; Easterling TR; Hebert MF
    Drug Metab Dispos; 2020 Apr; 48(4):264-271. PubMed ID: 31980499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population PK/PD analysis of metformin using the signal transduction model.
    Chae JW; Baek IH; Lee BY; Cho SK; Kwon KI
    Br J Clin Pharmacol; 2012 Nov; 74(5):815-23. PubMed ID: 22380769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes.
    Dissanayake AM; Wheldon MC; Hood CJ
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00424. PubMed ID: 30221006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
    Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.
    Hong Y; Rohatagi S; Habtemariam B; Walker JR; Schwartz SL; Mager DE
    J Clin Pharmacol; 2008 Jun; 48(6):696-707. PubMed ID: 18372428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of metformin.
    Graham GG; Punt J; Arora M; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup LC; Kirkpatrick CM; Ray JE; Timmins P; Williams KM
    Clin Pharmacokinet; 2011 Feb; 50(2):81-98. PubMed ID: 21241070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.
    Bardin C; Nobecourt E; Larger E; Chast F; Treluyer JM; Urien S
    Eur J Clin Pharmacol; 2012 Jun; 68(6):961-8. PubMed ID: 22274405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of vildagliptin.
    He YL
    Clin Pharmacokinet; 2012 Mar; 51(3):147-62. PubMed ID: 22339447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women.
    de Oliveira Baraldi C; Moisés EC; de Jesus Ponte Carvalho TM; de Jesus Antunes N; Lanchote VL; Duarte G; Cavalli RC
    Clin Pharmacokinet; 2012 Nov; 51(11):743-9. PubMed ID: 23018469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin.
    Dobbins R; Hussey EK; O'Connor-Semmes R; Andrews S; Tao W; Wilkison WO; Cheatham B; Sagar K; Hanmant B
    BMC Pharmacol Toxicol; 2021 Jun; 22(1):34. PubMed ID: 34120651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues.
    Zake DM; Kurlovics J; Zaharenko L; Komasilovs V; Klovins J; Stalidzans E
    PLoS One; 2021; 16(4):e0249594. PubMed ID: 33826656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and pharmacokinetics of metformin in patients with chronic liver disease.
    Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO
    Aliment Pharmacol Ther; 2020 Mar; 51(5):565-575. PubMed ID: 31960986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney function and age are both predictors of pharmacokinetics of metformin.
    Sambol NC; Chiang J; Lin ET; Goodman AM; Liu CY; Benet LZ; Cogan MG
    J Clin Pharmacol; 1995 Nov; 35(11):1094-102. PubMed ID: 8626883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin, renal function and lactate: the MetClear Study].
    Mitrov-Winkelmolen L; Oude Engberink RD; Roelofs R; Ponjee GA; Vleming LJ; Wilms EB; Geelhoed-Duijvestijn NH
    Ned Tijdschr Geneeskd; 2014; 158(5):A6266. PubMed ID: 24472334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
    Dostalek M; Sam WJ; Paryani KR; Macwan JS; Gohh RY; Akhlaghi F
    Clin Pharmacokinet; 2012 Sep; 51(9):591-606. PubMed ID: 22775412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.